Senior Director, Endometrial Cancer Brand Lead

Das ist der Job

Responsibilities Own the U.S.

Darum lohnt es sich

Requirements BS/BA required; advanced degree preferred (MBA, PharmD, PhD, MPH, or equivalent) 12+ years of commercial biopharmaceutical experience, including 7+ years in oncology marketing Launch, major lifecycle event, and/or new indication experience in oncology; solid tumor experience preferred Experience in endometrial cancer, gynecologic oncology, or related oncology markets preferred Proven success developing brand strategy and delivering commercial results Strong understanding of U.S. market access, reimbursement, and oncology treatment landscapes Experience leading cross‑functional teams in a fast‑paced biotech environment Exceptional strategic thinking, analytical, communication, and executive presentation skills Demonstrated ability to influence senior stakeholders and drive alignment across functions Hard Skills brand strategy commercial roadmap customer segmentation oncology marketing lifecycle planning launch strategy clinical evidence compliance strategic scenario work biopharmaceutical experience Soft Skills strategic thinking analytical skills communication skills executive presentation skills influencing skills cross‑functional leadership alignment driving stakeholder management team leadership fast‑paced environment adaptability Certifications & Qualifications BS/BA MBA PharmD PhD MPH Industry Keywords oncology endometrial cancer gynecologic oncology solid tumor U.S. market access reimbursement treatment landscapes commercial results key accounts integrated delivery networks #J-18808-Ljbffr EC brand strategy and multi-year commercial roadmap; deliver an annual Brand Plan/AOP with clear objectives, KPIs, milestones, and investment choices aligned to franchise and corporate priorities.

Define and evolve positioning, message platform, and customer value proposition; translate clinical and real-world evidence into differentiated, compliant claims and communications.

Lead lifecycle planning and strategic scenario work (e.g., competitive response, biomarker‑driven opportunities, combination strategies, line‑of‑therapy expansion opportunities, and treatment sequencing dynamics), partnering with cross‑functional leaders to evaluate options and trade‑offs. Drive U.S.

EC launch strategy and readiness from pivotal data readout through launch execution, defining launch milestones, critical path, and cross‑functional workstreams.

Develop customer segmentation and targeting strategy across key stakeholders, including gynecologic oncologists, medical oncologists, academic cancer centers, community oncology practices, integrated delivery networks, and key accounts.